QFW
GILD icon

QTR Family Wealth’s Gilead Sciences GILD Stock Holding History

QTR Family Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$280K Buy
2,217
+10
+0.5% +$1.32K 0.1% 234
2026
Q1 		$310K Hold
2,207
– – 0.13% 188
2025
Q4 		$325K Buy
2,207
+155
+8% +$18.8K 0.14% 167
2025
Q3 		$228K Buy
2,052
+3
+0.1% +$341 0.11% 219
2025
Q2 		$227K Buy
2,049
+104
+5% +$11.1K 0.14% 156
2025
Q1 		$218K Buy
+1,945
New +$201K 0.16% 147

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QTR Family Wealth's GILD Position: Q2 2026 in Review

QTR Family Wealth increased its Gilead Sciences (GILD) stake by 0.45% in Q2 2026, buying an estimated $1.32K and bringing the position to 2,217 shares worth $280K. The position accounts for 0.1% of the portfolio, ranked #234.

QTR Family Wealth first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $325K in Q4 2025. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • QTR Family Wealth held 2,217 shares of Gilead Sciences worth $280K as of Q2 2026.
  • QTR Family Wealth bought 10 Gilead Sciences shares in Q2 2026, an estimated $1.32K.
  • Gilead Sciences made up 0.1% of QTR Family Wealth's portfolio in Q2 2026, its #234 holding.
  • QTR Family Wealth first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
  • QTR Family Wealth's Gilead Sciences position peaked at $325K in Q4 2025.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on QTR Family Wealth's 13F filing for Q2 2026, filed 27 Jul 2026.